Free Newsletter
Register for our Free Newsletters
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
Company Directory
15 Hampshire Street
MA 02048
[t] 001 508 261 6330
Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence.

Covidien manufactures, distributes and services a diverse range of industry-leading product lines, including surgical devices, energy-based devices, respiratory and monitoring solutions, patient care and safety products, imaging solutions, pharmaceutical products, medical supplies and retail products.
Renal denervation programme to be discontinued
27 January, 2014
Poor market development in renal denervation has caused Covidien to exit the programme prior to completion
Sale completion of Confluent Surgical
20 January, 2014
The sale of Confluent Surgical to Integra LifeSciences from Covidien has been completed
Bedside monitor improves patient safety with sleep apnea recognition
14 October, 2013
The Capnostream Capnography monitor from Covidien can provide early cardiopulmonary complication warning through the detection of sleep apnea
Vessel sealing equipment with improved ergonomics
11 October, 2013
Surgical equipment supplier launches two new products into its LigaSure range of vessel sealing products with better ergonomic design
Covidien opens USD21m R&D and training & education centre in South Korea
28 August, 2013
Covidien is opening the Covidien Center of Innovation Korea (CCI Korea), which is the company's first research and development and training & education centre in Korea.
Covidien launches RF ablation catheter to eliminate need for multiple endoscope introductions
14 August, 2013
Covidien is expanding the company's portfolio of radiofrequency ablation (RFA) catheters with the launch of the Barrx Channel RFA Endoscopic Catheter for treating Barrett's esophagus and certain gastrointestinal bleeding disorders.
Covidien sells off pharmaceuticals business to Mallinckrodt
03 July, 2013
Covidien completes the separation of the company's Pharmaceuticals business, which is now held by Mallinckrodt, a new independent company.
Covidien clinches Gold Medical Design Excellence Award for cordless ultrasonic dissection system
25 June, 2013
Covidien's Sonicision cordless ultrasonic dissection system wins the 2013 Medical Design Excellence Award (MDEA), one of the medical technology industry's highest honours.
Study shows sequential compression sleeves reduce DVT events in immobile stroke patients
24 June, 2013
An independent study conducted by the University of Edinburgh demonstrates the effectiveness of Covidien's Kendall SCD system with Vascular Refill Detection Technology on immobile stroke patients.
Study shows Covidien embolization device offers safe and effective treatment of large aneurysms
18 June, 2013
Covidien reports that the final results of the PUFs (Pipeline for Uncoilable or Failed Aneurysms) clinical study of the company's Pipeline embolization device have been published in the June issue of Radiology (Ref 1) which is the official peer-reviewed medical journal of the Radiological Society of North America.
Pulse oximeters receive 510(k) clearance with labelling for use in newborn screening for CCHD
29 May, 2013
Covidien's Nellcor pulse oximetry portfolio facilitates quick, noninvasive screenings for CCHD.
Electromagnetic navigation bronchoscopy system is included in new ACCP guidelines to aid in diagnosing lung cancer
23 May, 2013
Covidien's superDimension Electromagnetic Navigation Bronchoscopy (ENB) system, the first technology of its kind, is included in the new American College of Chest Physicians (ACCP) guidelines to aid in diagnosing and managing lung cancer.
Covidien receives FDA 510(k) clearance for pulse oximetry motion claims
21 May, 2013
Covidien's Nellcor pulse oximetry portfolio, which is used to measure arterial oxygen saturation, receives US Food and Drug Administration (FDA) 510(k) clearance for motion claims.
Covidien launches new duo of surgical access devices
19 April, 2013
Covidien is launching two new surgical access devices at the annual meeting of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES).
Cuffless neonatal and paediatric tracheostomy tubes improve safety for young patients
17 April, 2013
Covidien is adding a new product to the company's family of Shiley neonatal and paediatric tracheostomy tubes.
Covidien completes patient enrollment in iliac stent clinical study series
21 February, 2013
Covidien completes patient enrollment in the company's iliac stent clinical study series which is composed of two prospective, multinational, multicentre studies - VISIBILITY Iliac and DURABILITY Iliac.
Two-year clinical study supports safety and efficacy of FR revascularization device
11 February, 2013
Covidien releases the results of the Solitaire FR Thrombectomy for Acute Revascularization (STAR) study which was a two-year study that evaluated the safety and efficacy of the Solitaire FR revascularization device in the treatment of acute ischemic stroke.
Covidien receives CE Mark approval for one-handed self-expanding peripheral stent
28 January, 2013
Covidien receives CE Mark approval for the company's EverFlex Self-expanding Peripheral Stent with Entrust Delivery System.
Covidien launches therapeutic device for treatment of resistant hypertension
17 January, 2013
Covidien is launching the OneShot Renal Denervation System, an over the wire balloon-based irrigated catheter technology for the treatment of high blood pressure or hypertension.
Covidien starts patient enrollment for acute ischemic stroke study
15 January, 2013
Covidien is launching a new study, SWIFT PRIME, which enrolled its first patient at the University at Buffalo.
Covidien acquires CV Ingenuity
14 January, 2013
Covidien completes the acquisition of CV Ingenuity.
Endoscopic surgical stapling platform passes USD1bn sales milestone
08 January, 2013
Covidien's Tri-Staple technology platform achieves more than $1 billion in product sales since launching the product in mid 2010.
Covidien plans to acquire CV Ingenuity
27 December, 2012
Covidien declares a definitive agreement to acquire CV Ingenuity with the companies expecting to complete the acquisition in the first calendar quarter of 2013.
Covidien expands production of enteral feeding pumps and sets
19 December, 2012
Covidien is expanding the capacity of the company's Kangaroo ePump and Kangaroo Joey enteral feeding pumps and sets.
Revascularization device receives regulatory approval in Canada
14 December, 2012
Covidien's Solitaire FR Revascularization Device, is used to restore blood flow to the brain in patients suffering from acute ischemic stroke, is approved by Health Canada.
GE Healthcare and Covidien collaborate to enhance infant safety and care in NICU
13 December, 2012
Covidien is integrating the company's industry-leading Nellcor pulse oximetry with OxiMax technology into GE Healthcare Giraffe and Panda infant warmers.
Covidien releases new surgical device for meniscal repair
06 December, 2012
Covidien is launching the AS Meniscal Repair Device which is the newest addition to the company's line of sports surgery devices and enables orthopaedic surgeons to perform 'all-inside', minimally invasive arthroscopic surgery to repair a torn meniscus in the knee using the gold standard 'all-suture' method of fixation.
NICE recommends BIS brain monitoring system to measure depth of anaesthesia
23 November, 2012
The UK-based National Institute for Health and Clinical Excellence (NICE) is recommending the use of electroencephalography (EEG)-based monitors, specifically the Bispectral Index (BIS) monitor, as an option for measuring depth of anaesthesia.
Study confirms effectiveness of directional atherectomy as a therapy to treat PAD
12 October, 2012
Covidien reveals final 12-month results from the company's DEFINITIVE LE (Determination of Effectiveness of SilverHawk/TurboHawk Peripheral Plaque Excision Systems for the Treatment of Infrainguinal Vessels/Lower Extremities) study.
Covidien receives FDA 510(k) clearance and CE Mark for bedside respiratory patient monitor
08 October, 2012
Covidien receives US Food and Drug Administration 510(k) clearance and European Economic Area (EEA) CE Mark approval for the Covidien Nellcor Bedside Respiratory Patient Monitoring system.
Covidien releases new device for endovascular treatment of peripheral vascular disease
18 September, 2012
Covidien is launching the Viance Crossing Catheter and Enteer Re-entry System for treating chronic total occlusions (CTOs) endovascularly.
Covidien receives 510(k) clearance of LigaSure Small Jaw Instrument for ENT surgery
12 September, 2012
Covidien receives 510(k) clearance from the US Food and Drug Administration (FDA) for the LigaSure curved, small jaw, open sealer/divider surgical instrument to be used in ear, nose and throat (ENT) procedures.
Covidien receives FDA 510(k) clearance for powered stapling system
30 August, 2012
Covidien obtains 510(k) clearance from the US Food and Drug Administration (FDA) for the iDrive Ultra powered stapling system.
Covidien supports new The Joint Commission's Sentinel Event Alert Recommendations
15 August, 2012
Covidien is announcing the company's support for The Joint Commission's recent Sentinel Alert recommendations for the 'Safe use of opioids in hospitals'.
Covidien opens USD45m research facility in China
06 August, 2012
Covidien is opening the company's China Technology Center (CTC) Research and Development (R and D) facility in Shanghai.
Covidien receives FDA 510(k) clearance for bedside SpO2 patient monitor
31 July, 2012
The US Food and Drug Administration (FDA) grants Covidien 510(k) clearance to market the Covidien Nellcor Bedside SpO2 Patient Monitoring System.
Covidien's Solitaire FR revascularization device receives regulatory approval in Brazil
23 July, 2012
Covidien's Solitaire FR Revascularization Device has been approved by Brazil's National Health Surveillance Agency.
New bipolar resection software application helps minimise hospital costs
16 July, 2012
Covidien unveils the North American introduction of a new bipolar resection in saline software application for its ForceTriad energy platform.
Covidien acquires Oridion Systems
28 June, 2012
Covidien completes the acquisition of Oridion Systems for an aggregate consideration of approximately $310 million, net of cash and investments acquired.
Covidien releases world's first knotless suture reload for laparoscopic procedures
22 June, 2012
Covidien is adding to the company's growing bariatric surgery portfolio of products and services designed to improve patient and surgeon experiences with weight loss surgery and other procedures.
Covidien launches bedside SpO2 patient monitoring system
08 June, 2012
Covidien is launching the Covidien Nellcor Bedside SpO2 Patient Monitoring System at the European Society of Anesthesiology Congress, held in Paris June 9-12, 2012.
Covidien releases new ablation catheter for treatment of Barrett's Oesophagus
21 May, 2012
Covidien launches the HALO90 ULTRA Ablation Catheter, the latest addition to the HALO family of catheters for the endoscopic treatment of Barrett's oesophagus.
Covidien acquires superDimension
17 May, 2012
Covidien completes the acquisition of superDimension, for an aggregate consideration of approximately $300 million, with future earn out payments possible.
Covidien signs five-year global collaboration deal with GE Healthcare
08 May, 2012
Covidien agrees a five-year, global collaboration with GE Healthcare to incorporate Covidien measurement technologies into GE Healthcare patient monitors.
Covidien finalises acquisition of Newport Medical Instruments
03 May, 2012
Covidien completes the acquisition of Newport Medical Instruments for an aggregate consideration of approximately $108 million, net of cash and short-term investments acquired.
Covidien prepares to acquire Oridion Systems
11 April, 2012
Covidien signs a definitive agreement to acquire Oridion Systems.
Covidien reveals method to measure OR ergonomics
06 April, 2012
Researchers develop a new method to measure the physical strain placed on surgeons while performing minimally invasive surgery reports Covidien.
Innovative endomechanical device focuses on ventral hernia repair
30 March, 2012
Covidien is launching the AccuMesh positioning system which is an innovative endomechanical device facilitates insertion, deployment and placement of Parietex optimised composite (PCOx) mesh during minimally invasive ventral hernia repair procedures.
Covidien plans to acquire Newport Medical Instruments
26 March, 2012
Covidien prepares a definitive agreement to acquire Newport Medical Instruments.
Covidien releases new respiration rate monitoring software
22 March, 2012
The US Food and Drug Administration (FDA) grants 510(k) clearance to Covidien to market the Covidien Nellcor Respiration Rate Version 1.0 software and the Adult Respiratory Sensor.
First | Prev  | 1 | 2  | Next  | Last
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   © 2012
Netgains Logo